Literature DB >> 12409429

In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.

Kenneth E Aldridge1, Megan O'Brien.   

Abstract

A comparison of antimicrobial susceptibility data of species of the Bacteroides fragilis group for 1989-1990 and 1998-1999 studies showed statistically significant increases or decreases in in vitro activity. Overall significant increases in resistance were noted for ampicillin-sulbactam and clindamycin, while significant decreases in resistance were noted for ertapenem and cefoxitin. Susceptibilities to piperacillin-tazobactam, imipenem, meropenem, and trovafloxacin remained virtually the same for the two studies. Importantly, a change in the rates of isolation of the various species showed the B. fragilis species comprised 58% of the isolates in 1989 to 1990 and 45% of the isolates in 1998 to 1999. This change in rates of isolation of B. fragilis versus non-B. fragilis species had an overall effect on susceptibility data.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409429      PMCID: PMC139666          DOI: 10.1128/JCM.40.11.4349-4352.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy.

Authors:  P Montravers; R Gauzit; C Muller; J P Marmuse; A Fichelle; J M Desmonts
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

Review 2.  Susceptibility testing of anaerobic bacteria.

Authors:  S M Finegold
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.

Authors:  J Oteo; B Aracil; J I Alós; J L Gómez-Garcés
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

6.  Attributable mortality of bacteremia associated with the Bacteroides fragilis group.

Authors:  M C Redondo; M D Arbo; J Grindlinger; D R Snydman
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

Review 7.  The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.

Authors:  K E Aldridge
Journal:  Am J Surg       Date:  1995-05       Impact factor: 2.565

8.  Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors:  F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

9.  Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors:  G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

10.  A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

Authors:  K E Aldridge; M Gelfand; L B Reller; L W Ayers; C L Pierson; F Schoenknecht; R C Tilton; J Wilkins; A Henderberg; D D Schiro
Journal:  Diagn Microbiol Infect Dis       Date:  1994-04       Impact factor: 2.803

View more
  5 in total

1.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 2.  Antibiotic regimens for postpartum endometritis.

Authors:  A Dhanya Mackeen; Roger E Packard; Erika Ota; Linda Speer
Journal:  Cochrane Database Syst Rev       Date:  2015-02-02

3.  Identification of Bacteroides thetaiotaomicron on the basis of an unexpected specific amplicon of universal 16S ribosomal DNA PCR.

Authors:  Lee-Jene Teng; Po-Ren Hsueh; Yu-Hsuan Huang; Jui-Chang Tsai
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Authors:  D R Snydman; N V Jacobus; L A McDermott; R Ruthazer; Y Golan; E J C Goldstein; S M Finegold; L J Harrell; D W Hecht; S G Jenkins; C Pierson; R Venezia; V Yu; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

5.  Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon.

Authors:  Mariam Yehya; Monzer Hamze; Hassan Mallat; Fouad Dabbousi
Journal:  Braz J Microbiol       Date:  2014-01-15       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.